|
GB0425658D0
|
|
Immunotherapeutic agent
|
|
GB0425437D0
|
|
Immunotherapeutic agent
|
|
WO03006035A1
|
|
Anti-emetic compositions comprising mycobacterial material
|
|
GB0117325D0
|
|
Therapeutic compositions
|
|
GB0116847D0
|
|
Therapeutic compositions
|
|
GB0106986D0
|
|
Immunotherapeutic agent
|
|
GB0106985D0
|
|
Immunotherapeutic agent
|
|
GB0106987D0
|
|
Immunotherapeuitic agent
|
|
US6432714B2
|
|
Prophylactic and therapeutic method
|
|
US2001018057A1
|
|
Mycobacterium vaccae for down-regulation of the Th2 activity of the immune system
|
|
GB0010496D0
|
|
Treatment of conditions of the central nervous system
|
|
GB9903539D0
|
|
Therapy using M.Vaccae
|
|
NZ336147A
|
|
Mycobacterium vaccae for down-regulation of the th2 activity without affecting (or up-regulation of) th1 activity
|
|
GB9723630D0
|
|
M.vaccae preparation and its use
|
|
AU3103097A
|
|
Compositions and methods for the treatment of chronic infections
|
|
GB9626859D0
|
|
Medical treatment
|
|
GB9626215D0
|
|
A therapeutic agent and its use
|
|
US6056964A
|
|
Immunotherapeutic agent and its use
|
